AVADEL PHARMACEUTICALS PLC — Director's Dealing 2024

Jan 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2024-01-16

Reporting Person: MCHUGH THOMAS S (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-16	ADSs	P	2000	$14.5	Acquired	80500	Direct

Footnotes

F1: The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the Issuer; ADSs may be represented by American Depositary Receipts.